Nan Fung Group Holdings »

Grail shares owned by Nan Fung Group Holdings

Quarter-by-quarter ownership of Grail (GRAL) shares owned by Nan Fung Group Holdings from 13F filings

Historical chart of Nan Fung Group Holdings investment in Grail

Tip: Access up to 7 years of quarterly data

All positions including Grail held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Grail by Nan Fung Group Holdings

Quarter filed Position value Share count Share price at filing
2024-06-30 $305k 20k 15.37

More positions owned by Nan Fung Group Holdings

Illumina (ILMN)
Harmony Biosciences Hldgs In (HRMY)
Merus N V (MRUS)
Geron Corporation (GERN)
Oculis Holding Ordinary Shares (OCS)
Incyte Corporation (INCY)
Exscientia Ads (EXAI)
Xenon Pharmaceuticals (XENE)
Longboard Pharmaceuticals In (LBPH)
Mirum Pharmaceuticals (MIRM)
D Fluidigm Corp Del (LAB)
Beigene Sponsored Adr (BGNE)
Kalvista Pharmaceuticals (KALV)
Rhythm Pharmaceuticals (RYTM)
Tourmaline Bio (TRML)

View all positions for Nan Fung Group Holdings

Top funds holding Grail

Sessa Capital IM
PRIMECAP Management Company
Vanguard Group
BlackRock
CRCM
Morgan Stanley
J. Goldman & Co
State Street Corporation
Geode Capital Management
Corvex Management
One Fin Capital Management
Bank of New York Mellon
Citadel Advisors
Jane Street
Nuveen Asset Management

View all funds holding Grail